Open Access

A Changing Paradigm: Defining the Future Role of SGLT-2 Inhibitors

Event: ESC Congress 2021 - The Digital Experience
Topic: Chronic Heart Failure
Session type: Satellite Symposium
Organised by Radcliffe Medical Education - Supported by an unrestricted educational grant from the Boehringer Ingelheim & Lilly Alliance
Date: 27 August 2021
Time: 15:00 - 15:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

6 presentations in this session

SGLT-2 Inhibitors in Heart Failure: Where are we now and where are we heading?

Speaker: Professor A. Coats (Coventry, GB)
Thumbnail

Summary of how the Tx paradigm for HF has changed.

Speaker: Professor B. Bozkurt (Houston, US)
Thumbnail

Unanswered Questions.

Speaker: Professor A. Coats (Coventry, GB)
Speaker: Professor B. Bozkurt (Houston, US)
Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

Best practice of SGLT-2 inhibitors in HFrEF: What constitutes best practice today?

Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

Implementation in Practice: What are the Practical Considerations?

Speaker: Professor A. Coats (Coventry, GB)
Speaker: Professor C. Lam (Singapore, SG)
Speaker: Professor B. Bozkurt (Houston, US)
Thumbnail

Q&A.

Speaker: Professor A. Coats (Coventry, GB)
Speaker: Professor B. Bozkurt (Houston, US)
Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

12 speakers from this session

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
96 presentations
14 followers

Professor Biykem Bozkurt

Baylor College of Medicine, Houston (United States of America)
14 presentations
2 followers

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
96 presentations
14 followers

Professor Biykem Bozkurt

Baylor College of Medicine, Houston (United States of America)
14 presentations
2 followers

Professor Carolyn Sp Lam

Duke-NUS Medical School, Singapore (Singapore)
103 presentations
22 followers

Professor Carolyn Sp Lam

Duke-NUS Medical School, Singapore (Singapore)
103 presentations
22 followers

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
96 presentations
14 followers

Professor Carolyn Sp Lam

Duke-NUS Medical School, Singapore (Singapore)
103 presentations
22 followers

Professor Biykem Bozkurt

Baylor College of Medicine, Houston (United States of America)
14 presentations
2 followers

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
96 presentations
14 followers

Professor Biykem Bozkurt

Baylor College of Medicine, Houston (United States of America)
14 presentations
2 followers

Professor Carolyn Sp Lam

Duke-NUS Medical School, Singapore (Singapore)
103 presentations
22 followers

This platform is supported by

logo Novo Nordisk